Richard Burton
Psychiatry · Gilbert, AZNPI 1598994287
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 804 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 804 payments — averaging $17.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Otsuka America Pharmaceutical, Inc.$1K
- Corium, LLC$1000
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$954
- Sunovion Pharmaceuticals Inc.$941
- Axsome Therapeutics, Inc.$803
- plus $6K from 27 others
What the payments were for
- Food & beverage$13,46098%
- Education$2202%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 180 | $2,494 |
| Otsuka America Pharmaceutical, Inc. | 98 | $1,448 |
| Corium, LLC | 56 | $1,000 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 47 | $954 |
| Sunovion Pharmaceuticals Inc. | 53 | $941 |
| Axsome Therapeutics, Inc. | 39 | $803 |
| Ironshore Pharmaceuticals Inc. | 43 | $772 |
| Tris Pharma Inc | 49 | $723 |
| Lundbeck LLC | 37 | $697 |
| Vanda Pharmaceuticals Inc. | 28 | $597 |
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $299 |
| Merck | 14 | $297 |
| Supernus Pharmaceuticals, Inc. | 14 | $289 |
| Almatica Pharma LLC | 10 | $275 |
| Johnson & Johnson | 12 | $245 |
| Teva Pharmaceuticals USA, Inc. | 12 | $231 |
| Jazz Pharmaceuticals Inc. | 11 | $218 |
| Bausch Health US, LLC | 12 | $212 |
| Alkermes, Inc. | 9 | $201 |
| Vertical Pharmaceuticals, LLC | 9 | $191 |
| Collegium Pharmaceutical, Inc. | 6 | $117 |
| Eisai Inc. | 7 | $115 |
| E.r. Squibb & Sons, L.L.C. | 5 | $95 |
| Idorsia Pharmaceuticals US Inc | 5 | $80 |
| Neos Therapeutics, LP | 5 | $77 |
| Adlon Therapeutics L.p. | 4 | $65 |
| Alfasigma USA, Inc. | 4 | $55 |
| Shire North American Group Inc | 4 | $53 |
| Biogen | 2 | $52 |
| Noven Therapeutics, LLC | 2 | $36 |
| Indivior Inc. | 1 | $21 |
| Sage Therapeutics, LLC | 1 | $15 |
| OWP Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$13,680 in reported general payments places this provider in the 95th percentile of 573 psychiatry providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clozapine | 23 | $1,597 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 35 | $1,086 |
| Bupropion XlBupropion Hcl | 29 | $1,063 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 19 | $794 |
| Duloxetine Hcl | 21 | $737 |
| Aripiprazole | 42 | $719 |
| Prazosin Hcl | 24 | $680 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 21 | $557 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 14 | $496 |
| Alprazolam | 78 | $487 |
| Trazodone Hcl | 17 | $467 |
| Lamotrigine | 42 | $449 |
| Doxepin Hcl | 17 | $435 |
| Quetiapine Fumarate | 17 | $434 |
| Clonazepam | 37 | $364 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $275 | $7515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 573 psychiatry providers in Arizona.
Other psychiatry in Gilbert
- Aaron DahlGilbert$12K
- Justin McKinleyGilbert$6K
- David ChongGilbert$4K
- Jason CaplanPhoenix$999K
- Thomas GazdaPhoenix$714K
- Monica BenavidezPhoenix$435K
- Bahar GolestanMesa$234K
- Eric ReimanPhoenix$157K
- Christopher LinskeyPage$100K
- Henry SchulteScottsdale$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.